146 related articles for article (PubMed ID: 33517120)
1. Establishment of human embryonic stem cell WAe009-A-48 carrying a long QT syndrome mutation in SCN5A.
Yang X; Wu F; Zhong J; Li F
Stem Cell Res; 2021 Mar; 51():102194. PubMed ID: 33517120
[TBL] [Abstract][Full Text] [Related]
2. Establishment of human embryonic stem cell WAe009-A-74 carrying a Long QT syndrome mutation in KCNH2.
Sun L; Zhong J; Wu F; Li F; Yang X; Zeng Z
Stem Cell Res; 2022 Apr; 60():102725. PubMed ID: 35247842
[TBL] [Abstract][Full Text] [Related]
3. Generation of a human embryonic stem cell line (WAe009-A-43) carrying a Long QT syndrome related mutation in KCNH2 gene.
Wu X; Zhao Y; Wang X
Stem Cell Res; 2020 Oct; 48():101976. PubMed ID: 32911324
[TBL] [Abstract][Full Text] [Related]
4. Generation of a human embryonic stem cell line WAe009-A-79 carrying a long QT syndrome mutation in KCNQ1.
Wang H; Guo T; Lan F
Stem Cell Res; 2023 Aug; 70():103119. PubMed ID: 37244124
[TBL] [Abstract][Full Text] [Related]
5. Establishment of human embryonic stem cell WAe009-A-88 carrying a long QT syndrome mutation in KCNH2.
Wen H; Sun L; Zhong J; Wu F
Stem Cell Res; 2022 Jul; 62():102795. PubMed ID: 35526388
[TBL] [Abstract][Full Text] [Related]
6. Modulating effects of age and gender on the clinical course of long QT syndrome by genotype.
Zareba W; Moss AJ; Locati EH; Lehmann MH; Peterson DR; Hall WJ; Schwartz PJ; Vincent GM; Priori SG; Benhorin J; Towbin JA; Robinson JL; Andrews ML; Napolitano C; Timothy K; Zhang L; Medina A;
J Am Coll Cardiol; 2003 Jul; 42(1):103-9. PubMed ID: 12849668
[TBL] [Abstract][Full Text] [Related]
7. Cardiac sodium channel mutation associated with epinephrine-induced QT prolongation and sinus node dysfunction.
Chen J; Makiyama T; Wuriyanghai Y; Ohno S; Sasaki K; Hayano M; Harita T; Nishiuchi S; Yuta Yamamoto ; Ueyama T; Shimizu A; Horie M; Kimura T
Heart Rhythm; 2016 Jan; 13(1):289-98. PubMed ID: 26282245
[TBL] [Abstract][Full Text] [Related]
8. Molecular biology of the long QT syndrome: impact on management.
Priori SG; Napolitano C; Paganini V; Cantù F; Schwartz PJ
Pacing Clin Electrophysiol; 1997 Aug; 20(8 Pt 2):2052-7. PubMed ID: 9272507
[TBL] [Abstract][Full Text] [Related]
9. Lidocaine attenuation testing: An in vivo investigation of putative LQT3-associated variants in the SCN5A-encoded sodium channel.
Anderson HN; Bos JM; Kapplinger JD; Meskill JM; Ye D; Ackerman MJ
Heart Rhythm; 2017 Aug; 14(8):1173-1179. PubMed ID: 28412158
[TBL] [Abstract][Full Text] [Related]
10. Sodium channel abnormalities are infrequent in patients with long QT syndrome: identification of two novel SCN5A mutations.
Wattanasirichaigoon D; Vesely MR; Duggal P; Levine JC; Blume ED; Wolff GS; Edwards SB; Beggs AH
Am J Med Genet; 1999 Oct; 86(5):470-6. PubMed ID: 10508990
[TBL] [Abstract][Full Text] [Related]
11. Exploring mutation specific beta blocker pharmacology of the pathogenic late sodium channel current from patient-specific pluripotent stem cell myocytes derived from long QT syndrome mutation carriers.
Comollo TW; Zou X; Zhang C; Kesters D; Hof T; Sampson KJ; Kass RS
Channels (Austin); 2022 Dec; 16(1):173-184. PubMed ID: 35949058
[TBL] [Abstract][Full Text] [Related]
12. Functional Consequences of the
Casini S; Albesa M; Wang Z; Portero V; Ross-Kaschitza D; Rougier JS; Marchal GA; Chung WK; Bezzina CR; Abriel H; Remme CA
Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31614475
[TBL] [Abstract][Full Text] [Related]
13. Specific Therapy Based on the Genotype in a Malignant Form of Long QT3, Carrying the V411M Mutation.
Blich M; Khoury A; Suleiman M; Lorber A; Gepstein L; Boulous M
Int Heart J; 2019 Jul; 60(4):979-982. PubMed ID: 31257342
[TBL] [Abstract][Full Text] [Related]
14. Ranolazine for Congenital Long-QT Syndrome Type III: Experimental and Long-Term Clinical Data.
Chorin E; Hu D; Antzelevitch C; Hochstadt A; Belardinelli L; Zeltser D; Barajas-Martinez H; Rozovski U; Rosso R; Adler A; Benhorin J; Viskin S
Circ Arrhythm Electrophysiol; 2016 Oct; 9(10):. PubMed ID: 27733495
[TBL] [Abstract][Full Text] [Related]
15. Human iPS cell model of type 3 long QT syndrome recapitulates drug-based phenotype correction.
Malan D; Zhang M; Stallmeyer B; Müller J; Fleischmann BK; Schulze-Bahr E; Sasse P; Greber B
Basic Res Cardiol; 2016 Mar; 111(2):14. PubMed ID: 26803770
[TBL] [Abstract][Full Text] [Related]
16. The congenital long QT syndrome Type 3: An update.
Pérez-Riera AR; Barbosa-Barros R; Daminello Raimundo R; da Costa de Rezende Barbosa MP; Esposito Sorpreso IC; de Abreu LC
Indian Pacing Electrophysiol J; 2018; 18(1):25-35. PubMed ID: 29101013
[TBL] [Abstract][Full Text] [Related]
17. [Molecular genetics in the hereditary form of long QT syndrome].
Georgijević Milić L
Med Pregl; 2000; 53(1-2):51-4. PubMed ID: 10953551
[TBL] [Abstract][Full Text] [Related]
18. Atrial Fibrillation in Long QT Syndrome by Genotype.
Platonov PG; McNitt S; Polonsky B; Rosero SZ; Zareba W
Circ Arrhythm Electrophysiol; 2019 Oct; 12(10):e007213. PubMed ID: 31610692
[TBL] [Abstract][Full Text] [Related]
19. Further Insights in the Most Common SCN5A Mutation Causing Overlapping Phenotype of Long QT Syndrome, Brugada Syndrome, and Conduction Defect.
Veltmann C; Barajas-Martinez H; Wolpert C; Borggrefe M; Schimpf R; Pfeiffer R; Cáceres G; Burashnikov E; Antzelevitch C; Hu D
J Am Heart Assoc; 2016 Jul; 5(7):. PubMed ID: 27381756
[TBL] [Abstract][Full Text] [Related]
20. A novel mutation in SCN5A, delQKP 1507-1509, causing long QT syndrome: role of Q1507 residue in sodium channel inactivation.
Keller DI; Acharfi S; Delacrétaz E; Benammar N; Rotter M; Pfammatter JP; Fressart V; Guicheney P; Chahine M
J Mol Cell Cardiol; 2003 Dec; 35(12):1513-21. PubMed ID: 14654377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
